ribavirin has been researched along with Alcoholism in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alavi, M; Dore, GJ; Law, MG | 1 |
Addis, MF; Babudieri, S; Cossu-Rocca, P; Dore, MP; Madeddu, G; Massarelli, G; Mura, MS; Nieddu, P; Pagnozzi, D; Soddu, A; Tanca, A; Uzzau, S | 1 |
Abenavoli, L; Brkic, S; Lendak, D; Pete, M; Preveden, T; Ruzic, M | 1 |
Alberti, A | 1 |
Mauss, S; Schaefer, M | 1 |
El-Zayadi, AR | 1 |
Almasio, PL; Cacopardo, B; Cosentino, S; Fatuzzo, F; Foti, G; Frugiuele, P; Galdieri, A; Guadagnino, V; Russello, M; Sapienza, M; Scalisi, I; Scifo, G; Spadaro, A; Stroffolini, T | 1 |
Abbacchi, A; Adewuyi, SA; Debold, C; Hong, BA; Lisker-Melman, M; North, CS; Pollio, DE | 1 |
Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS | 1 |
Brissot, P; Danielou, H; Deugnier, Y; Guillygomarc'h, A; Guyader, D; Lainé, F; Le Dréau, G; Le Lan, C; Moirand, R; Védeilhié, C | 1 |
Perlemuter, G | 1 |
Larrey, D | 1 |
Dhumeaux, D; Lerebours, E; Marcellin, P | 1 |
Shiffman, ML | 1 |
Brunette, MF; Iber, M; Luckoor, R; Mistler, LA; Rosenberg, SD; Vidaver, RM | 1 |
Buzatu, E; Cooper, CL; Dudas, J; Esguerra, R; Gorrell, MD; Haber, PS; Hilzenrat, N; Ionescu, C; Leo, MA; Lieber, CS; McCaughan, GW; Neuman, MG; Ramadori, G; Saile, B; Seth, D; Sha, K; Voiculescu, M; Winkler, RE; Wyse, J; Zakhari, S | 1 |
8 review(s) available for ribavirin and Alcoholism
Article | Year |
---|---|
What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
Topics: Alcoholism; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Hepatitis B; Hepatitis C, Chronic; HIV Infections; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Metabolic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Hepatitis C treatment in patients with drug addiction: clinical management of interferon-alpha-associated psychiatric side effects.
Topics: Alcoholism; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Illicit Drugs; Interferon alpha-2; Interferon-alpha; Methadone; Narcotics; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Substance Abuse, Intravenous | 2008 |
[Hepatitis C and alcohol].
Topics: Alanine Transaminase; Alcoholism; Antiviral Agents; Apoptosis; Biopsy; Carcinoma, Hepatocellular; Clinical Enzyme Tests; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Odds Ratio; Prevalence; Ribavirin; Risk Factors; Time Factors; Viral Load | 2002 |
[Chronic hepatitis C: apart from antiviral treatment what other measures should be recommended?].
Topics: Adult; Alcoholism; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Iron Deficiencies; Liver Transplantation; Male; Obesity; Patient Education as Topic; Ribavirin; Risk Factors; Smoking; Smoking Prevention; Time Factors | 2002 |
Consensus conference. Treatment of hepatitis C.
Topics: Adult; Aged; Alcoholism; Amantadine; Antiviral Agents; Body Weight; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Mental Disorders; Middle Aged; Monitoring, Physiologic; Quality of Life; Recurrence; Ribavirin; Risk Factors; Substance-Related Disorders; Time Factors | 2002 |
Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.
Topics: Adjuvants, Immunologic; Alcoholism; Amantadine; Antiviral Agents; Black or African American; Clinical Trials as Topic; Counseling; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Infusions, Intravenous; Injections, Subcutaneous; Interferons; Liver Cirrhosis; Meta-Analysis as Topic; Oligonucleotides, Antisense; Patient Compliance; Ribavirin; RNA, Viral; Thymalfasin; Thymosin; Time Factors; White People | 2004 |
Inflammation and repair in viral hepatitis C.
Topics: Alcoholism; Antiviral Agents; Carcinoma, Hepatocellular; Cytokines; Disease Progression; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Inflammation; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Ribavirin; Risk Factors | 2008 |
[International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
Topics: Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Alcoholism; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Diagnosis, Differential; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Substance-Related Disorders; Viral Hepatitis Vaccines | 1999 |
10 other study(ies) available for ribavirin and Alcoholism
Article | Year |
---|---|
Reply to: "'Who killed JR': Chronic hepatitis C or alcohol use disorders?"
Topics: Alcoholism; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Ribavirin | 2018 |
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver.
Topics: Adult; Alcoholism; Antiviral Agents; Diabetes Complications; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver; Polyethylene Glycols; Proteome; Proteomics; Recombinant Proteins; Ribavirin | 2013 |
Chronic Hepatitis C and Alcohol Abuse: The Single Center Experience of Novi Sad - Serbia.
Topics: Adult; Alcoholism; Antiviral Agents; Cross-Sectional Studies; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Retrospective Studies; Ribavirin; Serbia; Sustained Virologic Response | 2016 |
Hepatitis C comorbidities affecting the course and response to therapy.
Topics: Alcoholism; Antiviral Agents; Comorbidity; Gastroenterology; Hepatitis C; Humans; Interferons; Iron Overload; Polyethylene Glycols; Ribavirin; Schistosomiasis; Smoking; Treatment Outcome | 2009 |
Current practice of hepatitis C treatment in Southern Italy.
Topics: Adult; Aged; Alanine Transaminase; Alcoholism; Antiviral Agents; Educational Status; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Sex Factors; Treatment Outcome; Treatment Refusal | 2010 |
The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: a case report and discussion.
Topics: Adaptation, Psychological; Alcoholism; Antiviral Agents; Awareness; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Mental Disorders; Middle Aged; Patient Education as Topic; Problem Solving; Psychotherapy; Psychotherapy, Group; Recombinant Proteins; Recurrence; Ribavirin; Social Support; Substance Abuse, Intravenous; Suicidal Ideation | 2011 |
Racial differences in hepatitis C treatment eligibility.
Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People | 2011 |
A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse.
Topics: Adult; Alcoholism; Antiviral Agents; Behavior, Addictive; Case-Control Studies; Cohort Studies; Female; France; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prospective Studies; Ribavirin; Temperance; Time Factors; Treatment Outcome; Viral Load | 2012 |
[Treatment of hepatitis C: advances and consensus].
Topics: Aged; Alcoholism; Antiviral Agents; Carcinoma, Hepatocellular; Consensus Development Conferences as Topic; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferons; Liver Cirrhosis; Male; Paris; Research; Ribavirin; Risk Factors; Substance-Related Disorders | 2002 |
Case report of 3 patients with severe mental illness and chronic hepatitis C virus infection treated with interferon-alpha.
Topics: Adult; Alcoholics Anonymous; Alcoholism; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Antiviral Agents; Bipolar Disorder; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Female; Fluoxetine; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamotrigine; Male; Middle Aged; Patient Care Team; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Triazines; Viral Load | 2006 |